Predicting Unknown Interactions Between Known Drugs and Targets via Matrix Completion
暂无分享,去创建一个
Qing Liao | Qian Zhang | Naiyang Guan | Chengkun Wu | Naiyang Guan | Chengkun Wu | Qing Liao | Qian Zhang
[1] Yoshihiro Yamanishi,et al. Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..
[2] Hiroki Kobayashi,et al. Integrating Statistical Predictions and Experimental Verifications for Enhancing Protein-Chemical Interaction Predictions in Virtual Screening , 2009, PLoS Comput. Biol..
[3] J. Irwin,et al. Lead discovery using molecular docking. , 2002, Current opinion in chemical biology.
[4] Elena Marchiori,et al. Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..
[5] T. Ashburn,et al. Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.
[6] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[7] Hiroshi Mamitsuka,et al. A probabilistic model for mining implicit 'chemical compound-gene' relations from literature , 2005, ECCB/JBI.
[8] Emmanuel J. Candès,et al. A Singular Value Thresholding Algorithm for Matrix Completion , 2008, SIAM J. Optim..
[9] Stuart L. Schreiber,et al. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays , 2002, Nature.
[10] Antje Chang,et al. BRENDA , the enzyme database : updates and major new developments , 2003 .
[11] H. Yabuuchi,et al. Analysis of multiple compound–protein interactions reveals novel bioactive molecules , 2011, Molecular systems biology.
[12] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[13] J. Ballesteros,et al. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. , 2001, Current opinion in drug discovery & development.
[14] Yoshihiro Yamanishi,et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..
[15] Daniel R. Caffrey,et al. Structure-based maximal affinity model predicts small-molecule druggability , 2007, Nature Biotechnology.
[16] Chuang Liu,et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..
[17] Mehmet Gönen,et al. Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization , 2012, Bioinform..
[18] Chang Liu,et al. Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..
[19] Xiaobo Zhou,et al. Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.
[20] Stephen P. Boyd,et al. Convex Optimization , 2004, Algorithms and Theory of Computation Handbook.
[21] Hao Ding,et al. Similarity-based machine learning methods for predicting drug-target interactions: a brief review , 2014, Briefings Bioinform..
[22] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[23] Yasubumi Sakakibara,et al. Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data , 2007, Bioinform..
[24] Damian Szklarczyk,et al. STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..
[25] D. Bojanic,et al. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. , 2005, Drug discovery today.
[26] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[27] YamanishiYoshihiro,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008 .
[28] Yuhao Wang,et al. Predicting drug-target interactions using restricted Boltzmann machines , 2013, Bioinform..
[29] Mark Goadrich,et al. The relationship between Precision-Recall and ROC curves , 2006, ICML.
[30] Andrew L. Hopkins,et al. Drug discovery: Predicting promiscuity , 2009, Nature.
[31] J. Bajorath,et al. Compound promiscuity: what can we learn from current data? , 2013, Drug discovery today.
[32] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[33] Thomas Lengauer,et al. A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.
[34] Charles J. Manly,et al. The impact of informatics and computational chemistry on synthesis and screening. , 2001, Drug discovery today.
[35] J. Irwin,et al. Docking and chemoinformatic screens for new ligands and targets. , 2009, Current opinion in biotechnology.
[36] D. Butina,et al. Predicting ADME properties in silico: methods and models. , 2002, Drug discovery today.
[37] Ruth Nussinov,et al. Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.
[38] Dimitri P. Bertsekas,et al. Nonlinear Programming , 1997 .
[39] Sanjay Joshua Swamidass,et al. Mining small-molecule screens to repurpose drugs , 2011, Briefings Bioinform..
[40] Jens Sadowski,et al. Comparison of Support Vector Machine and Artificial Neural Network Systems for Drug/Nondrug Classification , 2003, J. Chem. Inf. Comput. Sci..
[41] Jean-Philippe Vert,et al. Protein-ligand interaction prediction: an improved chemogenomics approach , 2008, Bioinform..
[42] Gerhard Hessler,et al. Drug Design Strategies for Targeting G‐Protein‐Coupled Receptors , 2002, Chembiochem : a European journal of chemical biology.
[43] T. Klabunde. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands , 2007, British journal of pharmacology.
[44] S. Haggarty,et al. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. , 2003, Chemistry & biology.
[45] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[46] Laetitia Martin-Chanas,et al. Identify drug repurposing candidates by mining the Protein Data Bank , 2011, Briefings Bioinform..
[47] Yibo Wu,et al. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products , 2010, Bioinform..
[48] G. Golub,et al. Inexact and preconditioned Uzawa algorithms for saddle point problems , 1994 .
[49] Pierre Acklin,et al. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..
[50] Joel Dudley,et al. Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..
[51] Hao Ding,et al. Collaborative matrix factorization with multiple similarities for predicting drug-target interactions , 2013, KDD.
[52] Brian K. Shoichet,et al. Molecular docking using shape descriptors , 1992 .